In the BioHarmony Drug Report Database

"Preview" Icon

Fluticasone

Armonair Digihaler, Armonair Respiclick, Cutivate, Flonase, Flonase Relief, Flovent, Flovent Diskus, Flovent Hfa, Xhance, BroPair Spiromax, Seffalair Spiromax (fluticasone propionate) is a small molecule pharmaceutical. Fluticasone propionate was first approved as Armonair Digihaler on 1990-12-14. It is used to treat allergic rhinitis perennial in the USA. It has been approved in Europe to treat asthma. The pharmaceutical is active against glucocorticoid receptor. In addition, it is known to target mineralocorticoid receptor and progesterone receptor. Advair diskus’s patents are valid until 2038-12-18 (FDA).

 

Trade Name

 

BroPair Spiromax, Seffalair Spiromax
 

Common Name

 

fluticasone propionate
 

ChEMBL ID

 

CHEMBL1473
 

Indication

 

allergic rhinitis perennial, asthma
 

Drug Class

 

Steroids and steroid derivatives

Image (chem structure or protein)

Fluticasone structure rendering